Landmark UK Biobank proteomics study propels drug discovery

The research establishes the largest open-access proteogenomic dataset to date for the discovery of novel drug targets

Related Keywords

Naomi Allen , Chris Whelan , Nikolai Lenets , Johnson , Astrazeneca , Editorial Article , United Kingdom Biobank Pharma Proteomics Project , Kingdom Biobank , United Kingdom Biobank Pharma Proteomics , United Kingdom Biobank , Proximity Extension Assay , United Kingdom , Professor Naomi Allen , Chief Scientist , New Insights Into Human Disease That Could Propel Drug Development Revealed In Landmark Proteomic Studies Selectscience Bridges , Rotogenomic Studies , Disease Biology , Human Disease , Drug Development ,